Chemoinformaics analysis of S-2-propenyl (allyl)-l-cysteine sulfoxide
| Molecular Weight | 217.29 | nRot | 7 |
| Heavy Atom Molecular Weight | 202.17 | nRig | 3 |
| Exact Molecular Weight | 217.077 | nRing | 0 |
| Solubility: LogS | -0.535 | nHRing | 0 |
| Solubility: LogP | -1.723 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 31.4379 |
| nHD | 2 | BPOL | 19.9041 |
| QED | 0.473 |
| Synth | 5.216 |
| Natural Product Likeliness | 0.538 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.009 |
| HIA | 0.014 |
| CACO-2 | -5.607 |
| MDCK | 0.0000763 |
| BBB | 0.029 |
| PPB | 0.601954 |
| VDSS | 0.517 |
| FU | 0.335186 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.383 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.085 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.338 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.143 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.053 |
| CL | 2.35 |
| T12 | 0.827 |
| hERG | 0.002 |
| Ames | 0.448 |
| ROA | 0.108 |
| SkinSen | 0.038 |
| Carcinogencity | 0.243 |
| EI | 0.097 |
| Respiratory | 0.918 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.93837 |